Jennifer J. Hitchcock

650-335-7854
jhitchcock@fenwick.com
Partner
Corporate

Jennifer J.
Hitchcock

Jennifer J.
Hitchcock

Jennifer J.
Hitchcock

Partner
Corporate

Jen is a partner in Fenwick’s Capital Markets and Public Companies group advising technology and life sciences clients on capital markets and general public company corporate matters. Jen represents companies and underwriters in a wide range of capital markets transactions, including initial public offerings, direct listings and follow-on offerings in equity and debt. She also represents public companies in securities law compliance and disclosure matters and corporate governance matters.

Jen’s issuer-side initial public offerings include Coinbase (the first Nasdaq direct listing), Cloudera, Fitbit, Nurix Therapeutics, Peloton, Sutro Biopharma and UserTesting. Her underwriter-side initial public offerings include Adaptive Biotechnologies, AppLovin, Impinj, New Relic and Pivotal Software.

Jen has represented multiple public companies in their debt and follow-on equity offerings, including Agilent Technologies, Chegg, Cisco, Cloudera, Coinbase, Corium, Dermira, Fitbit, Nurix Therapeutics, Peloton and Veracyte.

Jen was recognized in 2023 as a leading lawyer in Capital Markets: Equity Offerings by The Legal 500, and Law360 named her as a “Rising Star for Capital Markets” in 2022.

Prior to joining Fenwick, Jen received her J.D. from the University of California, Berkely School of Law where she was a member of the Order of the Coif.

  • UserTesting initial public offering
  • Coinbase direct listing and convertible senior notes offering
  • Nurix Therapeutics initial public offering and follow-on public offering
  • Peloton initial public offering and convertible senior notes offering
  • Sutro Biopharma initial public offering
  • Cloudera initial public offering and follow-on public offering
  • Fitbit initial public offering and follow-on public offering
  • Chegg follow-on public offering and convertible senior notes offering
  • Dermira multiple follow-on public offerings and convertible senior notes offering
  • Corium International multiple follow-on public offerings
  • Veracyte follow-on public offering
  • Agilent Technologies senior notes offering
  • Cisco senior notes offering
  • AppLovin initial public offering*
  • Pivotal Software initial public offering*
  • Adaptive Biotechnologies initial public offering and follow-on public offerings*
  • Impinj initial public offering, follow-on public offering and convertible senior notes offering*
  • New Relic initial public offering*

*Representing the representatives on behalf of the underwriters/initial purchasers, including such investment banks as Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities, RBC Capital Markets, Allen & Company, Pacific Crest Securities, a division of KeyBanc Capital Markets, Piper Jaffray, and UBS Securities, among others.

  • UserTesting initial public offering
  • Coinbase direct listing and convertible senior notes offering
  • Nurix Therapeutics initial public offering and follow-on public offering
  • Peloton initial public offering and convertible senior notes offering
  • Sutro Biopharma initial public offering
  • Cloudera initial public offering and follow-on public offering
  • Fitbit initial public offering and follow-on public offering
  • Chegg follow-on public offering and convertible senior notes offering
  • Dermira multiple follow-on public offerings and convertible senior notes offering
  • Corium International multiple follow-on public offerings
  • Veracyte follow-on public offering
  • Agilent Technologies senior notes offering
  • Cisco senior notes offering
  • AppLovin initial public offering*
  • Pivotal Software initial public offering*
  • Adaptive Biotechnologies initial public offering and follow-on public offerings*
  • Impinj initial public offering, follow-on public offering and convertible senior notes offering*
  • New Relic initial public offering*

*Representing the representatives on behalf of the underwriters/initial purchasers, including such investment banks as Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities, RBC Capital Markets, Allen & Company, Pacific Crest Securities, a division of KeyBanc Capital Markets, Piper Jaffray, and UBS Securities, among others.

  • Coinbase
  • Goldman Sachs
  • JP Morgan
  • Morgan Stanley
  • Nurix Therapeutics
  • Pardes Biosciences
  • Shockwave Medical
  • The Arena Group
  • UserTesting

  • Coinbase
  • Goldman Sachs
  • JP Morgan
  • Morgan Stanley
  • Nurix Therapeutics
  • Pardes Biosciences
  • Shockwave Medical
  • The Arena Group
  • UserTesting

Recognition Recognition Recognition

Recognition Recognition Recognition

Recognition
Law360

2022

Named Jen a Law360 Rising Star for Capital Markets.

The Legal 500

2023

The Legal 500 recognized Jennifer as a leading lawyer in Capital Markets: Equity Offerings.

Recognition
Law360

2022

Named Jen a Law360 Rising Star for Capital Markets.

The Legal 500

2023

The Legal 500 recognized Jennifer as a leading lawyer in Capital Markets: Equity Offerings.